Von Hoff DD - Search Results

1

Second-line therapy after nab-paclitaxel plus gemcitabine or after gemcitabine for patients with metastatic pancreatic cancer.

Chiorean EG, Von Hoff DD, Tabernero J, El-Maraghi R, Ma WW, Reni M, Harris M, Whorf R, Liu H, Li JS, Manax V, Romano A, Lu B, Goldstein D. Chiorean EG, et al. Among authors: von hoff dd. Br J Cancer. 2016 Jul 12;115(2):188-94. doi: 10.1038/bjc.2016.185. Epub 2016 Jun 28. Br J Cancer. 2016. PMID: 27351217 Free PMC article. Clinical Trial.

2

A Southwest Oncology Group study on the use of a human tumor cloning assay for predicting response in patients with ovarian cancer.

Von Hoff DD, Kronmal R, Salmon SE, Turner J, Green JB, Bonorris JS, Moorhead EL, Hynes HE, Pugh RE, Belt RJ, et al. Von Hoff DD, et al. Cancer. 1991 Jan 1;67(1):20-7. doi: 10.1002/1097-0142(19910101)67:1<20::aid-cncr2820670105>3.0.co;2-u. Cancer. 1991. PMID: 1985717

3

Advances in the treatment of patients with pancreatic cancer: improvement in symptoms and survival time. The San Antonio Drug Development Team.

Von Hoff DD, Goodwin AL, Garcia L. Von Hoff DD, et al. Br J Cancer. 1998;78 Suppl 3(Suppl 3):9-13. doi: 10.1038/bjc.1998.748. Br J Cancer. 1998. PMID: 9717985 Free PMC article. Review.

4

A multicenter, phase II trial of weekly irinotecan (CPT-11) in patients with previously treated colorectal carcinoma.

Rothenberg ML, Cox JV, DeVore RF, Hainsworth JD, Pazdur R, Rivkin SE, Macdonald JS, Geyer CE Jr, Sandbach J, Wolf DL, Mohrland JS, Elfring GL, Miller LL, Von Hoff DD. Rothenberg ML, et al. Among authors: von hoff dd. Cancer. 1999 Feb 15;85(4):786-95. Cancer. 1999. PMID: 10091755 Clinical Trial.

5

Erlotinib plus gemcitabine in patients with unresectable pancreatic cancer and other solid tumors: phase IB trial.

Dragovich T, Huberman M, Von Hoff DD, Rowinsky EK, Nadler P, Wood D, Hamilton M, Hage G, Wolf J, Patnaik A. Dragovich T, et al. Among authors: von hoff dd. Cancer Chemother Pharmacol. 2007 Jul;60(2):295-303. doi: 10.1007/s00280-006-0389-0. Epub 2006 Dec 6. Cancer Chemother Pharmacol. 2007. PMID: 17149608 Clinical Trial.

6

Gemcitabine plus celecoxib in patients with advanced or metastatic pancreatic adenocarcinoma: results of a phase II trial.

Dragovich T, Burris H 3rd, Loehrer P, Von Hoff DD, Chow S, Stratton S, Green S, Obregon Y, Alvarez I, Gordon M. Dragovich T, et al. Among authors: von hoff dd. Am J Clin Oncol. 2008 Apr;31(2):157-62. doi: 10.1097/COC.0b013e31815878c9. Am J Clin Oncol. 2008. PMID: 18391600 Clinical Trial.

7

Validation of TPX2 as a potential therapeutic target in pancreatic cancer cells.

Warner SL, Stephens BJ, Nwokenkwo S, Hostetter G, Sugeng A, Hidalgo M, Trent JM, Han H, Von Hoff DD. Warner SL, et al. Among authors: von hoff dd. Clin Cancer Res. 2009 Nov 1;15(21):6519-28. doi: 10.1158/1078-0432.CCR-09-0077. Epub 2009 Oct 27. Clin Cancer Res. 2009. PMID: 19861455 Free PMC article.

8

A randomized phase II study of PX-12, an inhibitor of thioredoxin in patients with advanced cancer of the pancreas following progression after a gemcitabine-containing combination.

Ramanathan RK, Abbruzzese J, Dragovich T, Kirkpatrick L, Guillen JM, Baker AF, Pestano LA, Green S, Von Hoff DD. Ramanathan RK, et al. Among authors: von hoff dd. Cancer Chemother Pharmacol. 2011 Mar;67(3):503-9. doi: 10.1007/s00280-010-1343-8. Epub 2010 May 12. Cancer Chemother Pharmacol. 2011. PMID: 20461382 Clinical Trial.

9

Radiosensitization and stromal imaging response correlates for the HIF-1 inhibitor PX-478 given with or without chemotherapy in pancreatic cancer.

Schwartz DL, Bankson JA, Lemos R Jr, Lai SY, Thittai AK, He Y, Hostetter G, Demeure MJ, Von Hoff DD, Powis G. Schwartz DL, et al. Among authors: von hoff dd. Mol Cancer Ther. 2010 Jul;9(7):2057-67. doi: 10.1158/1535-7163.MCT-09-0768. Epub 2010 Jun 29. Mol Cancer Ther. 2010. PMID: 20587661 Free PMC article.

10

An effective personalized approach to a rare tumor: prolonged survival in metastatic pancreatic acinar cell carcinoma based on genetic analysis and cell line development.

Armstrong MD, Von Hoff D, Barber B, Marlow LA, von Roemeling C, Cooper SJ, Travis P, Campbell E, Paz-Fumagalli R, Copland JA, Colon-Otero G. Armstrong MD, et al. J Cancer. 2011 Mar 8;2:142-52. doi: 10.7150/jca.2.142. J Cancer. 2011. PMID: 21475719 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

772 results

Search Page

Filters